Fidelity Investments’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.12M Buy
793,451
+581,652
+275% +$3.98M ﹤0.01% 2174
2025
Q4
$1.16M Hold
211,799
﹤0.01% 2798
2025
Q3
$846K Sell
211,799
-21,986
-9% -$92.4K ﹤0.01% 2849
2025
Q2
$632K Buy
233,785
+10,633
+5% +$28.2K ﹤0.01% 2884
2025
Q1
$1.17M Buy
223,152
+2,314
+1% +$14.6K ﹤0.01% 2629
2024
Q4
$1.7M Sell
220,838
-68,597
-24% -$575K ﹤0.01% 2497
2024
Q3
$2.71M Buy
289,435
+3,178
+1% +$30.6K ﹤0.01% 2309
2024
Q2
$3.07M Buy
286,257
+1,305
+0.5% +$17.7K ﹤0.01% 2226
2024
Q1
$4.22M Sell
284,952
-31,994
-10% -$446K ﹤0.01% 2123
2023
Q4
$6.06M Sell
316,946
-88,840
-22% -$2.17M ﹤0.01% 2002
2023
Q3
$10.9M Buy
405,786
+72
+0% +$3.12K ﹤0.01% 1800
2023
Q2
$18.4M Buy
405,714
+57
+0% +$2.79K ﹤0.01% 1675
2023
Q1
$18.5M Sell
405,657
-21
-0% -$1.08K ﹤0.01% 1636
2022
Q4
$21.3M Buy
405,678
+43,947
+12% +$2.59M ﹤0.01% 1589
2022
Q3
$41.9M Buy
361,731
+36
+0% +$3.21K ﹤0.01% 1314
2022
Q2
$21.8M Sell
361,695
-120
-0% -$9.02K ﹤0.01% 1616
2022
Q1
$20.2M Buy
361,815
+418
+0.1% +$34.6K ﹤0.01% 1773
2021
Q4
$27.6M Hold
361,397
﹤0.01% 1668
2021
Q3
$50.8M Buy
+361,397
New +$42.4M ﹤0.01% 1403

Other funds holding RLYB

Fidelity Investments's RLYB Position: Q1 2026 in Review

Fidelity Investments increased its Rallybio (RLYB) stake by 275% in Q1 2026, buying an estimated $3.98M and bringing the position to 793,451 shares worth $7.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2174.

Fidelity Investments first reported a position in RLYB in Q3 2021 and has held it in 19 quarters since. The position peaked at $50.8M in Q3 2021. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • Fidelity Investments held 793,451 shares of Rallybio worth $7.12M as of Q1 2026.
  • Fidelity Investments bought 581,652 Rallybio shares in Q1 2026, an estimated $3.98M.
  • Rallybio made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2174 holding.
  • Fidelity Investments first reported a position in Rallybio in Q3 2021 and has held it in 19 quarters since.
  • Fidelity Investments's Rallybio position peaked at $50.8M in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.